Mafalda Casa-Nova

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Loss of HER2 and disease prognosis after neoadjuvant treatment of HER2+ breast cancer.

Francisco Branco, Duarte Machado, Filipa F Silva et al. · PubMed · 2019 · 43 citations · Full text

Medicine, Oncology, Breast Oncology +14

ONKOTEV Score as a Predictive Tool for Thromboembolic Events in Pancreatic Cancer—A Retrospective Analysis

João Godinho, Mafalda Casa-Nova, João Moreira-Pinto et al. · The Oncologist · 2019 · 29 citations · Full text

Medicine, Oncology, Cancer Epidemiology +15

Lymph node yield in the pathological staging of resected nonmetastatic colon cancer: The more the better?

Pedro Simões, Gonçalo Fernandes, Beatriz Costeira et al. · Surgical Oncology · 2022 · 15 citations · Full text

Medicine, Oncology, Surgery +17

Febrile Neutropenia in Patients with Solid Tumors Undergoing Intravenous Chemotherapy

João Moreira-Pinto, Inês Leão, Carolina Palmela et al. · Oncology Research and Treatment · 2020 · 12 citations

Medicine, Hematology, Oncology +13